TY - JOUR
T1 - Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas
AU - Dorris, Kathleen
AU - Sobo, Matthew
AU - Onar-Thomas, Arzu
AU - Panditharatna, Eshini
AU - Stevenson, Charles B.
AU - Gardner, Sharon L.
AU - Dewire, Mariko D.
AU - Pierson, Christopher R.
AU - Olshefski, Randal
AU - Rempel, Sandra A.
AU - Goldman, Stewart
AU - Miles, Lili
AU - Fouladi, Maryam
AU - Drissi, Rachid
N1 - Funding Information:
Acknowledgments We thank Kelly Verel, Nicole Reinholdt, Adr-ianne Gerkhardt, Marcela White, and Dr. Rachel Brody for their hard work on sample and data collection. We thank Rebecca Turner for her assistance with sample collection and regulatory support. We thank Dr. Mi-Ok Kim and Chunyan Liu for their statistical input. Rachid Drissi was supported by an Institutional and Translational Science Award, NIH/NCRR Grant number UL1RR026314. Kathleen Dorris was supported by grant National Institute of Environmental Health Sciences T32 ES010957. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. Some tumor samples were obtained from patients treated on a Cincinnati Children’s Hospital Medical Center clinical trial that was supported by Genentech. Some of these data were previously presented at a poster session at the 2011 Society of Neuro-Oncology Annual Meeting.
PY - 2014/3
Y1 - 2014/3
N2 - Children with high-grade glioma, including diffuse intrinsic pontine glioma (DIPG), have a poor prognosis despite multimodal therapy. Identifying novel therapeutic targets is critical to improve their outcome. We evaluated prognostic roles of telomere maintenance mechanisms in children with HGG, including DIPG. A multi-institutional retrospective study was conducted involving 50 flash-frozen HGG (35 non-brainstem; 15 DIPG) tumors from 45 children (30 non-brainstem; 15 DIPG). Telomerase activity, expression of hTERT mRNA (encoding telomerase catalytic component) and TERC (telomerase RNA template) and alternative lengthening of telomeres (ALT) mechanism were assayed. Cox Proportional Hazard regression analyses assessed association of clinical and pathological variables, TERC and hTERT levels, telomerase activity, and ALT use with progression-free or overall survival (OS). High TERC and hTERT expression was detected in 13/28 non-brainstem HGG samples as compared to non-neoplastic controls. High TERC and hTERT expression was identified in 13/15 and 11/15 DIPG samples, respectively, compared to controls. Evidence of ALT was noted in 3/11 DIPG and 10/19 non-brainstem HGG specimens. ALT and telomerase use were identified in 4/19 non-brainstem HGG and 2/11 DIPG specimens. In multivariable analyses, increased TERC and hTERT levels were associated with worse OS in patients with non-brainstem HGG, after controlling for tumor grade or resection extent. Children with HGG and DIPG, have increased hTERT and TERC expression. In children with non-brainstem HGG, increased TERC and hTERT expression levels are associated with a worse OS, making telomerase a promising potential therapeutic target in pediatric HGG.
AB - Children with high-grade glioma, including diffuse intrinsic pontine glioma (DIPG), have a poor prognosis despite multimodal therapy. Identifying novel therapeutic targets is critical to improve their outcome. We evaluated prognostic roles of telomere maintenance mechanisms in children with HGG, including DIPG. A multi-institutional retrospective study was conducted involving 50 flash-frozen HGG (35 non-brainstem; 15 DIPG) tumors from 45 children (30 non-brainstem; 15 DIPG). Telomerase activity, expression of hTERT mRNA (encoding telomerase catalytic component) and TERC (telomerase RNA template) and alternative lengthening of telomeres (ALT) mechanism were assayed. Cox Proportional Hazard regression analyses assessed association of clinical and pathological variables, TERC and hTERT levels, telomerase activity, and ALT use with progression-free or overall survival (OS). High TERC and hTERT expression was detected in 13/28 non-brainstem HGG samples as compared to non-neoplastic controls. High TERC and hTERT expression was identified in 13/15 and 11/15 DIPG samples, respectively, compared to controls. Evidence of ALT was noted in 3/11 DIPG and 10/19 non-brainstem HGG specimens. ALT and telomerase use were identified in 4/19 non-brainstem HGG and 2/11 DIPG specimens. In multivariable analyses, increased TERC and hTERT levels were associated with worse OS in patients with non-brainstem HGG, after controlling for tumor grade or resection extent. Children with HGG and DIPG, have increased hTERT and TERC expression. In children with non-brainstem HGG, increased TERC and hTERT expression levels are associated with a worse OS, making telomerase a promising potential therapeutic target in pediatric HGG.
KW - High-grade glioma
KW - Pediatric
KW - Telomerase
UR - http://www.scopus.com/inward/record.url?scp=84901620090&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84901620090&partnerID=8YFLogxK
U2 - 10.1007/s11060-014-1374-9
DO - 10.1007/s11060-014-1374-9
M3 - Article
C2 - 24477622
AN - SCOPUS:84901620090
SN - 0167-594X
VL - 117
SP - 67
EP - 76
JO - Journal of Neuro-Oncology
JF - Journal of Neuro-Oncology
IS - 1
ER -